Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-05-16
1989-11-07
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 16, 514 21, 530329, 530330, A61K 3702, C07K 706
Patent
active
048792780
ABSTRACT:
A new cytostatic depsipeptide, designated "dolastatin 15", was isolated from the Indian Ocean shell-like mollusk Dolabella auricularia. Dolastatin 15 inhibited growth of the PS leukemia with ED.sub.50 0.0024 .mu.g/mL. Pharmaceutical preparations and therapeutic regimens utilizing Dolastatin 15, its synthetic counterpart and pharmaceutically active derivatives are disclosed. Dolastatin 15 has the structural formula: ##STR1##
REFERENCES:
patent: 4414205 (1983-11-01), Pettit
patent: 4486414 (1984-12-01), Pettit
patent: 4816444 (1989-03-01), Pettit et al.
Kamano Yoshiaki
Pettit George R.
Arizona Board of Regents
Lee Lester L.
Mybeck Richard R.
LandOfFree
Isolation and structural elucidation of the cytostatic linear de does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolation and structural elucidation of the cytostatic linear de, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolation and structural elucidation of the cytostatic linear de will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-83892